PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20977674-1	2010	Dentatorubral-pallidoluysian atrophy is caused by polyglutamine (polyQ) expansion in atrophin-1 (ATN1).	polyglutamine	50-63	atrophin 1	Mus musculus	97-101	
34968706-3	2022	Aggregation of the polyglutamine-expanded ATN1 protein causes neuro-degeneration of the dentatorubral and pallidoluysian systems.	polyglutamine	19-32	atrophin 1	Mus musculus	42-46	
20977674-1	2010	Dentatorubral-pallidoluysian atrophy is caused by polyglutamine (polyQ) expansion in atrophin-1 (ATN1).	polyglutamine	65-70	atrophin 1	Mus musculus	97-101	
20977674-2	2010	Recent studies have shown that nuclear accumulation of ATN1 and cleaved fragments with expanded polyQ is the pathological process underlying neurodegeneration in dentatorubral-pallidoluysian atrophy.	polyglutamine	96-101	atrophin 1	Mus musculus	55-59	
19681162-1	2009	Dentatorubral-pallidoluysian atrophy (DRPLA) is a dominant hereditary neurodegenerative disorder caused by the expansion of a poly-glutamine (poly-Q) repeat in Atrophin-1 protein.	polyglutamine	126-140	atrophin 1	Mus musculus	38-43	
19681162-1	2009	Dentatorubral-pallidoluysian atrophy (DRPLA) is a dominant hereditary neurodegenerative disorder caused by the expansion of a poly-glutamine (poly-Q) repeat in Atrophin-1 protein.	polyglutamine	126-140	atrophin 1	Mus musculus	160-170	
19681162-1	2009	Dentatorubral-pallidoluysian atrophy (DRPLA) is a dominant hereditary neurodegenerative disorder caused by the expansion of a poly-glutamine (poly-Q) repeat in Atrophin-1 protein.	polyglutamine	142-148	atrophin 1	Mus musculus	38-43	
19681162-1	2009	Dentatorubral-pallidoluysian atrophy (DRPLA) is a dominant hereditary neurodegenerative disorder caused by the expansion of a poly-glutamine (poly-Q) repeat in Atrophin-1 protein.	polyglutamine	142-148	atrophin 1	Mus musculus	160-170	
19681162-7	2009	These results support the model that poly-Q expanded Atrophin-1 proteins cause DRPLA in a manner independent of any functional interaction with wild-type Atrophin-1 proteins.	polyglutamine	37-43	atrophin 1	Mus musculus	53-63	
19681162-7	2009	These results support the model that poly-Q expanded Atrophin-1 proteins cause DRPLA in a manner independent of any functional interaction with wild-type Atrophin-1 proteins.	polyglutamine	37-43	atrophin 1	Mus musculus	79-84	
12165555-0	2002	Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington"s disease mouse models reveal context-independent effects.	polyglutamine	0-13	atrophin 1	Mus musculus	67-72	
16407196-1	2006	Dentatorubral-pallidoluysian atrophy (DRPLA) is a progressive neurodegenerative disease caused by polyglutamine expansion within the Atrophin-1 protein.	polyglutamine	98-111	atrophin 1	Mus musculus	38-43	
16407196-1	2006	Dentatorubral-pallidoluysian atrophy (DRPLA) is a progressive neurodegenerative disease caused by polyglutamine expansion within the Atrophin-1 protein.	polyglutamine	98-111	atrophin 1	Mus musculus	133-143	
16407196-7	2006	These results support the hypothesis that transcription deregulation plays an important role in the pathogenesis of polyglutamine expansion diseases and suggest that reversion of transcription repression with small molecules such as sodium butyrate is a feasible approach to treating DRPLA symptoms.	polyglutamine	116-129	atrophin 1	Mus musculus	284-289	
16891319-11	2006	These results suggest that neuronal atrophy is an essential feature of the cell pathology in DRPLA and that this is closely related to polyglutamine pathogenesis and development of the clinical phenotype.	polyglutamine	135-148	atrophin 1	Mus musculus	93-98	
10973986-1	2000	Dentato-rubral and pallido-luysian atrophy (DRPLA) is one of the family of neurodegenerative diseases caused by expansion of a polyglutamine tract.	polyglutamine	127-140	atrophin 1	Mus musculus	44-49	
10677044-1	1999	Dentatorubral and pallidoluysian atrophy (DRPLA) is a member of a family of progressive neurodegenerative diseases caused by polyglutamine repeat expansion.	polyglutamine	125-138	atrophin 1	Mus musculus	42-47	
9020849-1	1997	Six inherited neurodegenerative diseases are caused by a CAG/polyglutamine expansion, including spinal and bulbar muscular atrophy (SBMA), Huntington"s disease (HD), spinocerebellar ataxia type 1 (SCA1), dentatorubral pallidoluysian atrophy (DRPLA) Machado-Joseph disease (MJD or SCA3) and SCA2.	polyglutamine	61-74	atrophin 1	Mus musculus	242-247	
11696439-5	2001	The preferential association of intranuclear polyglutamine aggregates with coiled bodies was also confirmed in the dentatorubral-pallidoluysian atrophy transgenic mouse brain and culture cells expressing mutant atrophin-1.	polyglutamine	45-58	atrophin 1	Mus musculus	211-221